BioNexus Gene Lab
BGLC
BGLC
5 hedge funds and large institutions have $55.9K invested in BioNexus Gene Lab in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.09K |
Top Sellers
| 1 |
HF
HRT Financial
New York
|
-$38K |
| 2 |
VF
Virtu Financial
New York
|
-$18K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$9.79K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$4.28K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $18.1K | -$9.79K | -1,816 | -35% |
|
|
VF
2
Virtu Financial
New York
| $14K | -$18K | -3,354 | -56% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $12.8K | – | – | – |
|
|
TSS
4
Two Sigma Securities
New York
| $7.91K | -$4.28K | -807 | -35% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3.09K | +$3.09K | +583 | New |
|
|
HF
6
HRT Financial
New York
| – | -$38K | -4,547 | Closed |
|